@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .

nalt:25591
  skos:prefLabel "neostigmina"@es, "neostigmine"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:related nalt:22191 .

nalt:2520
  skos:prefLabel "parasimpaticomiméticos"@es, "parasympathomimetics"@en ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  skos:related nalt:22191 .

nalt:22191
  skos:broader nalt:25590 ;
  skos:hiddenLabel "acetyl-cholinesterase inhibitors"@en, "cholinesterase-inhibitors"@en, "acetyl-cholinesterase inhibitor"@en, "anti-cholinesterase"@en, "anticholinesterase agent"@en, "acetylcholinesterase inhibitor"@en, "anticholinesterase drug"@en ;
  dc:created "2006-01-19"^^xsd:date ;
  dc:modified "2019-12-16"^^xsd:date ;
  skos:altLabel "anticholinesterase agents"@en, "acetylcholinesterase inhibitors"@en, "anticholinesterase drugs"@en, "anti-cholinesterases"@en ;
  skos:related nalt:2520, nalt:22186, nalt:264440, nalt:25591, nalt:10497 ;
  skos:prefLabel "cholinesterase inhibitors"@en, "inhibidores de la colinesterasa"@es ;
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  ns0:marc001 "8261" ;
  skos:exactMatch <http://id.loc.gov/authorities/subjects/sh85024658> ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:definition nalt:22191_def .

ns0:Chemical
  rdfs:label "Chemical"@en ;
  a owl:Class .

nalt:10497
  skos:prefLabel "carbaryl"@es, "carbaryl"@en ;
  a ns0:Chemical, skos:Concept ;
  skos:related nalt:22191 .

nalt:25590
  skos:prefLabel "inhibidores enzimáticos"@es, "enzyme inhibitors"@en ;
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:22191 .

nalt:264440
  skos:prefLabel "agentes neurotóxicos"@es, "nerve agents"@en ;
  a ns0:Chemical, skos:Concept ;
  skos:related nalt:22191 .

nalt:22191_def
  rdf:value "Fármacos que inhiben las colinesterasas. El neurotransmisor denominado acetilcolina es rápidamente hidrolizado y, por tanto, inactivado por las colinesterasas. Cuando las colinesterasas son inhibidas, se potencia la acción de la acetilcolina liberada en forma endógena en las sinapsis colinérgicas. A los inhibidores de la colinesterasa se les da un uso clínico amplio para potenciar sus insumos colinérgicos en el tracto gastrointestinal y la vejiga urinaria, los ojos y los músculos esqueléticos. Además, se utilizan por sus efectos en el corazón y en el sistema nervioso central."@es, "Drugs that inhibit cholinesterases. The neurotransmitter acetylcholine is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system."@en ;
  dc:source "Medical Subject Headings" ;
  a ns0:Definition .

<https://lod.nal.usda.gov/nalt>
  rdfs:label "NALT Full"@en ;
  a skos:ConceptScheme .

nalt:22186
  skos:prefLabel "fisostigmina"@es, "physostigmine"@en ;
  a ns0:Chemical, skos:Concept ;
  skos:related nalt:22191 .